Related Experiment Video
Updated: Jun 21, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Proteomic analysis in interstitial lung diseases: a review
Paola Rottoli1, Elena Bargagli, Claudia Landi
1Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy. rottoli@unisi.it
Current Opinion in Pulmonary Medicine
|July 14, 2009
Summary
Recent proteomic findings offer new insights into interstitial lung diseases (ILDs). Proteomics, particularly using bronchoalveolar lavage fluid, aids in diagnosing ILDs and understanding disease progression.
Area of Science:
- Pulmonology
- Biochemistry
- Proteomics
Background:
- Interstitial lung diseases (ILDs) encompass a heterogeneous group of disorders.
- Understanding the molecular mechanisms of ILDs is crucial for effective treatment.
Purpose of the Study:
- To review recent proteomic findings in tissues and biological fluids for ILDs.
- To discuss the application of new technologies in ILD proteomic studies.
Main Methods:
- Review of recent literature on proteomics in interstitial lung diseases.
- Analysis of proteomic data from various biological samples, including tissue and fluids.
- Focus on novel technologies applied to proteomic analysis.
Main Results:
- Proteomics has revealed new insights into lung cell biology and pathogenic pathways in ILDs.
- Potential therapeutic targets and specific biomarkers for ILDs have been identified through proteomic studies.
- Bronchoalveolar lavage fluid is highlighted as a promising biological fluid for ILD proteomic analysis.
Conclusions:
- Proteomic research provides valuable information for the clinical management of ILDs.
- Findings can aid in the diagnosis, assessment of disease progression, and severity of ILDs.
- Further application of proteomics holds promise for advancing ILD patient care.
